Oncolytics Biotech Inc T.ONC

No-one has access to ONCY's manufacturing process

[Noteable]

Other than MerckKGaA's CMO Sigma Millapore.

[itntdf]

4.11 Contract Manufacturer. Oncolytics may meet its obligations to supply the Licensed Product to Licensee hereunder or under the Supply Agreement through subcontracting with Third Parties jointly selected, qualified and validated by Licensee and Oncolytics (each, a “Contract Manufacturer”), subject to the following requirements and Clause 4.10:  

[Noteable]

It's obvious that ITNTDF is here only to harass and that's very typical of a hedge fund seeking to acquire stock.

[Quentin30]

hmmm, I don't think it's 'evident'... why do you get so sh*tty when someone has a different opinion Noteable? Or post ad infinitum to bury another's post so that it's gets missed. wow... you really are a piece of work... still waiting to see you workings on how you value ONCY... go on, see if you can do some sums, rather than just copy paste.... LOL Cancel culture is so

[Noteable]

Harassment is more than a difference of opinion.

[westcoast1000]

it is not obvious to me. How about giving it a rest. 

[Angler101]

West coast....cmon man.....even you’re picking on Notable now?!....I have a feeling if you had a quarter as many posters constantly attacking you, you’d wanna start lashing out yourself!.... I know I would......

[Noteable]

Yep, "evident". Just as evident as the level of harassment that I'm receiving for just posting the facts that 'traders' find offensive.

[Noteable]

And yep, "obvious". Just as obvious as the nose on your "two-faces".

[fox7mf]

No need bickering with each other boys and girls. I think most of us are on the same side, and want little more than to see Onc succeed & BP get Pela to market. The interminable blackout & the SP getting pounded into oblivion certainly contributes to the frayed nerves.

[Noteable]

Merck KGaA and Pfizer have even a greater interest in ONCY given their long-standing relationship through Merck KGaA's CMO - Sigma Millipore's manufacturing/fill n finish of ONCY's clinical ready supply of pelareorep. Pfizer has recently expanded its biologics manufacturing capacity in a number of sites in Europe and North America.